Nov 12,2018

DarioHealth's Digital Diabetes Platform to be Made Available to 4.6 Million Customers at Giant Eagle, One of America's Largest Supermarket Chains

DarioHealth Corp., a leading global digital health company with mobile health and big data solutions, announced today it has signed an agreement for the rollout of a Digital Diabetes Education and Rewards Program, powered by Dario, to Giant Eagle's consumers through the pharmacy's 214 locations.

COLLABORATION PARTNERSHIP

#institution

#mobile app

View Analyst & Ambassador Comments
Go to original news
Nov 13,2018

Tandem Diabetes Care to Present at the Credit Suisse Healthcare Conference

Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that Kim Blickenstaff, President and Chief Executive Officer and Leigh Vosseller, EVP and Chief Financial Officer, will present at the Credit Suisse 27th Annual Healthcare Conference on Wednesday, November 14, 2018 in Scottsdale, AZ at 12:20pm Eastern Time (9:20am Pacific).

CONFERENCES
View Analyst & Ambassador Comments
Go to original news
Nov 13,2018

DarioHealth Reports Third Quarter 2018 Results

DarioHealth's revenue for the third quarter ended September 30, 2018 was $1.88 million, a 37% increase from $1.37 million in the third quarter ended September 30, 2017. Revenue for the third quarter of 2018 included direct-to-consumer sales in the United States and Australia, as well as sales in Germany, and product sales to distributors in the United Kingdom and Canada.

View Analyst & Ambassador Comments
Go to original news
Nov 14,2018

ASCENSIA DIABETES CARE HIGHLIGHTS THE SUPPORT THAT FAMILIES PROVIDE FOR PEOPLE WITH DIABETES TO MARK WORLD DIABETES DAY 2018

Today, Ascensia Diabetes Care, a global leading diabetes care company, launched their campaign for World Diabetes Day 2018 to celebrate the important role of families for people with diabetes. They are publishing 38 online artworks that tell the stories of how families support, inspire and impact people with diabetes and the management of their condition. The Family and Diabetes was chosen by the International Diabetes Federation (IDF) as the 2018-2019 theme for World Diabetes Day.

View Analyst & Ambassador Comments
Go to original news
Nov 14,2018

Nemaura Medical to Present at the Canaccord Genuity Medical Technologies & Diagnostics Forum

Nemaura Medical Inc. (NASDAQ: NMRD), a medical technology company developing sugarBEAT® as a non-invasive, affordable and flexible continuous glucose monitor (CGM) for use by people with diabetes and pre-diabetics, today announced that Chief Business Officer, Bashir Timol, will be presenting at the Canaccord Genuity Medical Technologies & Diagnostics Forum on Thursday, November 15, 2018 in New York.

CONFERENCES
View Analyst & Ambassador Comments
Go to original news
Nov 14,2018

Virta Health Puts 100% of Fees at Risk with Announcement of New Pricing Structure

Virta Health, the first company to safely and sustainably reverse type 2 diabetes without the use of medications or surgery, today announced a unique value-based care model that puts 100% of its fees at risk. Under Virta’s new payment structure, employers and health plans pay an enrollment fee only after an engagement milestone is met, ensuring patients stay active during the critical early stages of treatment. After that, every dollar, and the majority of overall payment, is at-risk and tied to health improvement based on diabetes reversal metrics such as HbA1c reduction.

PRODUCT
View Analyst & Ambassador Comments
Go to original news
Nov 14,2018

DarioHealth's Diabetes Digital Health Solution Now Available at Best Buy

DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health company with mobile health and big data solutions, announced today that the Dario Blood Glucose Monitor has been included in Best Buy's growing portfolio of digital healthcare services and products.

PRODUCT

#bgm

View Analyst & Ambassador Comments
Go to original news
Nov 15,2018

Brighter's Interim report July-September 2018.

Over the third quarter, the Company reported that capitalized expenditure for development work reached SEK 2,404 thousand, and operating income amounted to SEK 2,655 thousand.

View Analyst & Ambassador Comments
Go to original news
Nov 19,2018

Insulet to Present at Upcoming Investor Conferences

Insulet Corporation (NASDAQ: PODD) (Insulet), the global leader in tubeless insulin pump technology with its Omnipod® Insulin Management System, today announced that management will present at two upcoming investor conferences: The 30th Annual Piper Jaffray Healthcare Conference in New York City on Wednesday, November 28, 2018, at 9:00 a.m. (Eastern Time), and The NASDAQ 39th Investor Conference in London on Wednesday, December 5, 2018, at 10:30 a.m. (Greenwich Mean Time).

CONFERENCES
View Analyst & Ambassador Comments
Go to original news
Nov 20,2018

Nemaura Signs License and Distribution Agreement for SugarBEAT® Commercial Launch in Qatar

Nemaura Medical Inc. (NASDAQ: NMRD), a medical technology company developing sugarBEAT® as a non-invasive, affordable and flexible Continuous Glucose Monitor (CGM) for use by persons with diabetes and pre-diabetics, today announced that it has signed an exclusive license and distribution agreement with Al-Danah Medical Co. for the commercial launch of sugarBEAT® in Qatar in readiness for 2019 launch.

COLLABORATION PARTNERSHIP

#institution

#cgm

View Analyst & Ambassador Comments
Go to original news
Subscribe to DIABETES